Determination of expression level of AP1S1, CDK9, FIGF and HDAC11 genes in bladder tumors for aggressive phenotype characterization
Bladder cancer holds a steady 10th place among oncological diseases. Follow-up and timely diagnosis of recurrence and progression of bladder cancer are still based on regular but outdated cystoscopy followed by cytological examination. To reduce the number of cystoscopy procedures, new and reliable...
Saved in:
| Main Authors: | Olga Antonova, Zora Hammoudeh, Zornitza Yordanova, Boris Mladenov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-03-01
|
| Series: | Biotechnology & Biotechnological Equipment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/13102818.2023.2253926 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis
by: Jinbeom Heo, et al.
Published: (2019-11-01) -
LINC00525 drives aggressive phenotypes in bladder cancer via YAP stabilization-mediated transcriptional activation
by: Jiaming Liang, et al.
Published: (2025-06-01) -
PACAP/PAC1 regulation in cystitis rats: induction of bladder inflammation cascade leading to bladder dysfunction
by: Hanwei Ke, et al.
Published: (2024-11-01) -
Role of TGF-?1 in Urinary Bladder Carcinoma
by: Baghdad Science Journal
Published: (2014-12-01) -
PRR11 Promotes Bladder Cancer Growth and Metastasis by Facilitating G1/S Progression and Epithelial‐Mesenchymal Transition
by: Lu Wang, et al.
Published: (2025-03-01)